Abstract Cardiogenic shock is a highly lethal syndrome, leading to rapid death or secondary multiorgan damage, but current therapies, including mechanical support devices, also have significant side effect profile. The overarching goal of therapy ensuring long-term survival with good quality life. This implies averting death, modifying the disease course by promoting heart recovery and avoiding...

PurposeTransthyretin amyloidosis (ATTR) predominantly involves the heart (ATTR-cardiac [CA]) and nerves, may involve other organs or tissues. Disease modifying therapies improve outcomes in those with ATTR-CA neurologic involvement, however their utility post transplant (HT) combined heart/liver is uncertain. We evaluated patients who underwent HT for to determine incidence of de novo developme...